Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: techmover, BZstocks, DDStocks, HighYieldStocks, Mykkus, SK510
Search This Board: 
Last Post: 4/19/2018 7:58:35 AM - Followers: 454 - Board type: Free - Posts Today: 11

Welcome to the Ihub Arrayit Corporatio (ARYC) board  

Arrayit Corporation (ARYC) is a Silicon Valley biotech company that is currently trading at a low fraction of its actual worth. Please review the listed links, see the actual sales of this Silicon Valley company through their daily updates on Twitter (@Arrayit) and understand the incredible potential that this company has.  

Arrayit Corporation  
927 Thompson Place  
Sunnyvale, CA 94085  
Phone 408-744-1331  
FAX 408-744-1711  


Publications and Social Networking:  

Arrayit products have been featured in 5,000+ scientific publications.
Follow Arrayit on Twitter, Facebook, Yahoo Finance, $ARYC and iHub. 
Arrayit Corporation News Feed
Arrayit Store
Corporate Overview
Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.
Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries. Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.

No share increase per CEO (I.E. NO DILUTION)

Outstanding: 1,055,279,527 
Restricted: 21,490,723 
Float: 1,033,788,804 

Standard Registrar and Transfer Company, Inc. 
440 East 400 South, Suite 200 
Salt Lake City, UT 84111 
Phone: 801-571-8844 or 801-596-2150 
Fax: 801-328-4058

Estimated earnings of $8 million last year and it is also located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry. 

2 contracts signed last year for a total of approximately $51 million over the next 3 years ......

No other OTC company has the potential of ARYC  

Arrayit's new corporate headquarters, features 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities

Arrayit Headquarters Drive By(Click to view)
Arrayit Store sales exceed $55,000,000 all time on 230,706 products and services sold since on-line inception



ARYC also owns 40 million shares of AVDX(Click to visit Advant Diagnostics)

Enabling physicians to make personalized treatment recommendations for cancer patients

Avant Diagnostics, Inc. (formerly known as Theranostics Health, Inc.) is a medical diagnostic technology company focused on commercializing innovative biomarker technologies that have the potential to dramatically improve treatment outcomes in the areas of oncology and neurology. The Company's lead technology, called Theralink(r), was developed to empower cancer treating physicians with actionable information make time sensitive treatment decisions for their patients. Theralink was designed to inform physicans which treatments are likely to be effective for their patients at any given moment in time, and also identify which treamtents are unlikely to be effective. This information has the potential to improve treatment efficacy and reduce side effects by foregoing ineffective therapy.

Cancer tumor biomarker profiling: Driving innovation in personalized medicine

At Avant Diagnostics, our approach is based on more than 10 years of research and development that informs our philosophy the genetic information alone is insufficient to make patient specific treatment recommendations. Our phospho-proteomic approach, which focuses on measuring the quantity and intensity of drug target activation in the tumor tissue following standard biopsy procedures, exploits our understanding of drug-receptor interaction that is the driver of treatment response . Our advanced technology is being developed to reduce the prescription of ineffective, toxic treatments and guide physicians towards therapies that are most likely to lead to positive responses to treatment. Our large panel of markers targeted at already-approved FDA drugs, as well as certain investigational therapies, makes Theralink an invaluable tool for oncologists.

Market opportunity: Cancer biomarkers market expected to reach $33B by 2025

According to Grand View Research, the market for cancer biomarkers is expected to grow from $10.3B in 2016 to $33.7B by 2025, representing a compound annual growth rate (CAGR) of 14.6%. The market is currently comprised primarily of genetic biomarkers that have good predictive value on a population basis, but limited value on an individual patient basis. Proteomic markers represent a growing segment of the cancer biomarker market, and offer the promise to improve individual patient outcomes based upon the individual patient's tumor proteomic profile.

Within the proteomic cancer biomarker category, phosphoprotein analysis represents a uniquely positioned asset class that can more robustly predict treatment outcomes based upon the molecular mechanisms driving tumor growth and treatment resistance. As such, the Company believes it has the potential to be the market leader in this phospho-proteomic subcategory.

OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.

Human genome

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ARYC News: Statement of Ownership (sc 13g) 03/22/2018 02:12:50 PM
ARYC News: Initial Statement of Beneficial Ownership (3) 03/19/2018 06:37:10 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#75691  Sticky Note Below are my finding from my tour at Jeffpacman 03/30/18 11:28:30 AM
#74305  Sticky Note UPDATED 3-21: ARYC Potential revenue streams partial list: BZstocks 03/21/18 08:56:51 PM
#70614  Sticky Note NEWS out!! *********************** Arrayit sales and marketing team Mykkus 03/01/18 07:44:03 PM
#67208  Sticky Note Silicon Valley Biotech Arrayit (ARYC) is located in SK510 02/07/18 05:39:06 PM
#66938  Sticky Note For those who are new to Arrayit Corporation, HighYieldStocks 02/06/18 09:21:39 AM
#66899  Sticky Note New investors: Please take a moment to review DDStocks 02/05/18 06:05:23 PM
#77607   I'm not sure what is going on anymore, GM5 04/19/18 08:06:48 AM
#77606   I think you have valid points in your millionaireonpaper 04/19/18 07:58:35 AM
#77605   It looks like some insiders have nicks on Hugie 04/19/18 07:26:50 AM
#77604   Yeah right. The same MMs will help in techmover 04/19/18 07:25:08 AM
#77603   suspension is looming big time over this!!! jrsh 04/19/18 07:23:18 AM
#77602   Can easily.It has been kept up only by Hugie 04/19/18 07:22:58 AM
#77601   I doubt it will drop that low. Come on. techmover 04/19/18 06:45:25 AM
#77600   Long time investor here and I'm adding more. GVInvestments 04/19/18 02:28:07 AM
#77599   Nothing is so important as financials now.Products or Hugie 04/19/18 01:39:05 AM
#77598   It has been over a half year since Hugie 04/19/18 01:37:26 AM
#77597   It will get back around 0,005. Hugie 04/19/18 01:34:12 AM
#77596 UndervaluedStocks 04/18/18 11:49:11 PM
#77592   Probably need a few more LAST conference calls mfdesigner 04/18/18 09:17:57 PM
#77591   Lol a slow decline. Down 25% but still BIGBUCKS 04/18/18 09:06:12 PM
#77590   i will sell when the financials come out.. hbhmb 04/18/18 08:27:45 PM
#77589   I think we have started a slow decline techmover 04/18/18 07:59:20 PM
#77588   Let the weak hands go ;) Ace508 04/18/18 04:56:50 PM
#77587   Please let me know whenever you decide to Ace508 04/18/18 04:40:57 PM
#77586   Everyone here should learn to practice the law Play4keeps2 04/18/18 04:17:08 PM
#77585   there is only one reason this is being hbhmb 04/18/18 04:05:57 PM
#77584   Only credible and non - delinquent companies can Hugie 04/18/18 04:02:48 PM
#77583   I'm wondering if, once '14 and '15 fins Play4keeps2 04/18/18 03:08:55 PM
#77582   Real good find UVS...thanks a lot for sharing HighYieldStocks 04/18/18 03:07:39 PM
#77581   you may notice when people are questioned about hbhmb 04/18/18 03:06:32 PM
#77580   Nice find UVS! DDStocks 04/18/18 02:58:42 PM
#77579   Financials or was that a lie?! Liuhisn 04/18/18 02:57:56 PM
#77578   Nice!! BZstocks 04/18/18 02:57:28 PM
#77577   just took more shares...tired of this being held down HighYieldStocks 04/18/18 02:44:54 PM
#77576   Oh!!! What is this????!!!! UndervaluedStocks 04/18/18 02:31:45 PM
#77575   A possibility of Arrayit's current will make many glory2000 04/18/18 02:31:30 PM
#77574   Possibility of Arrayit suspension will put off many Hugie 04/18/18 02:09:12 PM
#77573   Post #67028 Quote: It is strange but I Ace508 04/18/18 01:39:24 PM
#77572   A person with no credibility can re-post as Ace508 04/18/18 01:38:36 PM
#77571   A company with no any little credibility as Hugie 04/18/18 01:31:18 PM
#77570   NEW tweet...Arrayit sales and marketing team reports microarray HighYieldStocks 04/18/18 01:24:08 PM
#77569   NEW tweet...Arrayit sales and marketing team reports microarray HighYieldStocks 04/18/18 01:23:46 PM
#77568   NEW tweet...Arrayit sales and marketing team reports microarray HighYieldStocks 04/18/18 01:23:38 PM
#77567   NEW tweet...Arrayit business development team reports business-to-busines HighYieldStocks 04/18/18 01:23:29 PM
#77566   NEW tweet...Arrayit sales and marketing team invited to HighYieldStocks 04/18/18 01:23:21 PM
#77564   For someone who doesn't believe the tweets it's Jeffpacman 04/18/18 01:08:45 PM
#77562   Arrayit is heavily in debts and it does Hugie 04/18/18 01:08:05 PM
#77561   That's all right, he'll burn his bridges without techmover 04/18/18 01:05:59 PM
#77560   Just means the float is drying up and millionaireonpaper 04/18/18 01:00:53 PM
#77559   Did you get Franks permission to repost his tweet? Penny Traders Club 04/18/18 01:00:13 PM
#77558   This is unbelievably hilarious. Mykkus 04/18/18 12:58:44 PM
#77557   Tweeted response to ARYC'S last tweet from somebody rh22 04/18/18 12:53:07 PM
#77556   I often bash stocks I invest in, right Hugie? techmover 04/18/18 12:50:07 PM
#77555   Both the Schena's and RRBB have gone to ground. rh22 04/18/18 12:49:49 PM
#77554   Only a few people on this board probably Hugie 04/18/18 12:41:52 PM
#77553   Feel free to sell/not to buy. Mykkus 04/18/18 12:40:19 PM